nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Anastrozole—breast cancer	0.135	0.401	CbGbCtD
Phenylephrine—CYP1A2—Toremifene—breast cancer	0.124	0.367	CbGbCtD
Phenylephrine—CYP1A2—Tamoxifen—breast cancer	0.0452	0.134	CbGbCtD
Phenylephrine—CYP1A2—Fluorouracil—breast cancer	0.0333	0.0987	CbGbCtD
Phenylephrine—Edrophonium—ACHE—breast cancer	0.00375	0.368	CrCbGaD
Phenylephrine—Edrophonium—BCHE—breast cancer	0.00221	0.217	CrCbGaD
Phenylephrine—Terbutaline—BCHE—breast cancer	0.00167	0.164	CrCbGaD
Phenylephrine—Tapentadol—CYP2D6—breast cancer	0.00067	0.0657	CrCbGaD
Phenylephrine—Salbutamol—CYP3A4—breast cancer	0.000585	0.0574	CrCbGaD
Phenylephrine—Epinephrine—TNF—breast cancer	0.000545	0.0535	CrCbGaD
Phenylephrine—Isoprenaline—CYP1A1—breast cancer	0.000493	0.0484	CrCbGaD
Phenylephrine—Loss of consciousness—Paclitaxel—breast cancer	0.000295	0.00065	CcSEcCtD
Phenylephrine—Mediastinal disorder—Docetaxel—breast cancer	0.000295	0.000649	CcSEcCtD
Phenylephrine—Rash—Melphalan—breast cancer	0.000294	0.000647	CcSEcCtD
Phenylephrine—Paraesthesia—Gemcitabine—breast cancer	0.000294	0.000647	CcSEcCtD
Phenylephrine—Cardiac disorder—Capecitabine—breast cancer	0.000294	0.000647	CcSEcCtD
Phenylephrine—Dermatitis—Melphalan—breast cancer	0.000294	0.000647	CcSEcCtD
Phenylephrine—Arrhythmia—Docetaxel—breast cancer	0.000292	0.000643	CcSEcCtD
Phenylephrine—Dyspnoea—Gemcitabine—breast cancer	0.000292	0.000642	CcSEcCtD
Phenylephrine—Nausea—Vinblastine—breast cancer	0.000291	0.000641	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Epirubicin—breast cancer	0.000291	0.000641	CcSEcCtD
Phenylephrine—Abdominal pain upper—Epirubicin—breast cancer	0.000291	0.000641	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Irinotecan—breast cancer	0.00029	0.000639	CcSEcCtD
Phenylephrine—Hypertension—Paclitaxel—breast cancer	0.00029	0.000638	CcSEcCtD
Phenylephrine—Vomiting—Goserelin—breast cancer	0.000289	0.000637	CcSEcCtD
Phenylephrine—Paraesthesia—Fluorouracil—breast cancer	0.000289	0.000636	CcSEcCtD
Phenylephrine—Pruritus—Vinorelbine—breast cancer	0.000288	0.000635	CcSEcCtD
Phenylephrine—Pain—Mitoxantrone—breast cancer	0.000287	0.000633	CcSEcCtD
Phenylephrine—Pain—Irinotecan—breast cancer	0.000287	0.000633	CcSEcCtD
Phenylephrine—Angiopathy—Capecitabine—breast cancer	0.000287	0.000632	CcSEcCtD
Phenylephrine—Dyspnoea—Fluorouracil—breast cancer	0.000287	0.000632	CcSEcCtD
Phenylephrine—Rash—Goserelin—breast cancer	0.000287	0.000631	CcSEcCtD
Phenylephrine—Hypersensitivity—Thiotepa—breast cancer	0.000287	0.000631	CcSEcCtD
Phenylephrine—Dermatitis—Goserelin—breast cancer	0.000287	0.000631	CcSEcCtD
Phenylephrine—Mental disorder—Docetaxel—breast cancer	0.000286	0.000631	CcSEcCtD
Phenylephrine—Immune system disorder—Capecitabine—breast cancer	0.000286	0.000629	CcSEcCtD
Phenylephrine—Chest pain—Paclitaxel—breast cancer	0.000286	0.000629	CcSEcCtD
Phenylephrine—Mediastinal disorder—Capecitabine—breast cancer	0.000285	0.000628	CcSEcCtD
Phenylephrine—Headache—Goserelin—breast cancer	0.000285	0.000627	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000284	0.000625	CcSEcCtD
Phenylephrine—Nausea—Tamoxifen—breast cancer	0.000283	0.000623	CcSEcCtD
Phenylephrine—Arrhythmia—Capecitabine—breast cancer	0.000283	0.000623	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000283	0.000622	CcSEcCtD
Phenylephrine—Pain—Gemcitabine—breast cancer	0.00028	0.000616	CcSEcCtD
Phenylephrine—Dysgeusia—Docetaxel—breast cancer	0.000279	0.000614	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000278	0.000612	CcSEcCtD
Phenylephrine—Mental disorder—Capecitabine—breast cancer	0.000277	0.000611	CcSEcCtD
Phenylephrine—Nausea—Melphalan—breast cancer	0.000277	0.00061	CcSEcCtD
Phenylephrine—Pruritus—Thiotepa—breast cancer	0.000275	0.000606	CcSEcCtD
Phenylephrine—Pain—Fluorouracil—breast cancer	0.000275	0.000606	CcSEcCtD
Phenylephrine—Nausea—Goserelin—breast cancer	0.00027	0.000595	CcSEcCtD
Phenylephrine—Dysgeusia—Capecitabine—breast cancer	0.00027	0.000594	CcSEcCtD
Phenylephrine—Shock—Paclitaxel—breast cancer	0.00027	0.000594	CcSEcCtD
Phenylephrine—Dizziness—Vinorelbine—breast cancer	0.000269	0.000593	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Doxorubicin—breast cancer	0.000269	0.000593	CcSEcCtD
Phenylephrine—Abdominal pain upper—Doxorubicin—breast cancer	0.000269	0.000593	CcSEcCtD
Phenylephrine—Nervous system disorder—Paclitaxel—breast cancer	0.000269	0.000592	CcSEcCtD
Phenylephrine—Tachycardia—Paclitaxel—breast cancer	0.000267	0.000589	CcSEcCtD
Phenylephrine—Urticaria—Mitoxantrone—breast cancer	0.000267	0.000588	CcSEcCtD
Phenylephrine—Skin disorder—Paclitaxel—breast cancer	0.000266	0.000586	CcSEcCtD
Phenylephrine—Hyperhidrosis—Paclitaxel—breast cancer	0.000265	0.000583	CcSEcCtD
Phenylephrine—Epinephrine—CYP3A4—breast cancer	0.000264	0.0259	CrCbGaD
Phenylephrine—Vision blurred—Capecitabine—breast cancer	0.00026	0.000572	CcSEcCtD
Phenylephrine—Vomiting—Vinorelbine—breast cancer	0.000259	0.00057	CcSEcCtD
Phenylephrine—Tremor—Capecitabine—breast cancer	0.000258	0.000568	CcSEcCtD
Phenylephrine—Dizziness—Thiotepa—breast cancer	0.000257	0.000566	CcSEcCtD
Phenylephrine—Rash—Vinorelbine—breast cancer	0.000257	0.000566	CcSEcCtD
Phenylephrine—Dermatitis—Vinorelbine—breast cancer	0.000257	0.000565	CcSEcCtD
Phenylephrine—Urticaria—Fluorouracil—breast cancer	0.000256	0.000563	CcSEcCtD
Phenylephrine—Headache—Vinorelbine—breast cancer	0.000255	0.000562	CcSEcCtD
Phenylephrine—Syncope—Docetaxel—breast cancer	0.000255	0.000562	CcSEcCtD
Phenylephrine—Palpitations—Docetaxel—breast cancer	0.000251	0.000554	CcSEcCtD
Phenylephrine—Loss of consciousness—Docetaxel—breast cancer	0.00025	0.000551	CcSEcCtD
Phenylephrine—Hypersensitivity—Mitoxantrone—breast cancer	0.000248	0.000545	CcSEcCtD
Phenylephrine—Hypersensitivity—Irinotecan—breast cancer	0.000248	0.000545	CcSEcCtD
Phenylephrine—Vomiting—Thiotepa—breast cancer	0.000247	0.000545	CcSEcCtD
Phenylephrine—Syncope—Capecitabine—breast cancer	0.000247	0.000544	CcSEcCtD
Phenylephrine—Paraesthesia—Paclitaxel—breast cancer	0.000246	0.000542	CcSEcCtD
Phenylephrine—Hypertension—Docetaxel—breast cancer	0.000246	0.000541	CcSEcCtD
Phenylephrine—Rash—Thiotepa—breast cancer	0.000245	0.00054	CcSEcCtD
Phenylephrine—Dermatitis—Thiotepa—breast cancer	0.000245	0.00054	CcSEcCtD
Phenylephrine—Dyspnoea—Paclitaxel—breast cancer	0.000244	0.000538	CcSEcCtD
Phenylephrine—Headache—Thiotepa—breast cancer	0.000244	0.000537	CcSEcCtD
Phenylephrine—Palpitations—Capecitabine—breast cancer	0.000243	0.000536	CcSEcCtD
Phenylephrine—Chest pain—Docetaxel—breast cancer	0.000242	0.000533	CcSEcCtD
Phenylephrine—Loss of consciousness—Capecitabine—breast cancer	0.000242	0.000533	CcSEcCtD
Phenylephrine—Nausea—Vinorelbine—breast cancer	0.000242	0.000533	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000241	0.00053	CcSEcCtD
Phenylephrine—Hypertension—Capecitabine—breast cancer	0.000238	0.000524	CcSEcCtD
Phenylephrine—Hypersensitivity—Fluorouracil—breast cancer	0.000237	0.000522	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000237	0.000521	CcSEcCtD
Phenylephrine—Chest pain—Capecitabine—breast cancer	0.000235	0.000516	CcSEcCtD
Phenylephrine—Pain—Paclitaxel—breast cancer	0.000234	0.000516	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000233	0.000513	CcSEcCtD
Phenylephrine—Pruritus—Gemcitabine—breast cancer	0.000232	0.00051	CcSEcCtD
Phenylephrine—Nausea—Thiotepa—breast cancer	0.000231	0.000509	CcSEcCtD
Phenylephrine—Shock—Docetaxel—breast cancer	0.000229	0.000503	CcSEcCtD
Phenylephrine—Nervous system disorder—Docetaxel—breast cancer	0.000228	0.000501	CcSEcCtD
Phenylephrine—Pruritus—Fluorouracil—breast cancer	0.000228	0.000501	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—breast cancer	0.000227	0.0005	CcSEcCtD
Phenylephrine—Tachycardia—Docetaxel—breast cancer	0.000227	0.000499	CcSEcCtD
Phenylephrine—Skin disorder—Docetaxel—breast cancer	0.000226	0.000497	CcSEcCtD
Phenylephrine—Bradycardia—Epirubicin—breast cancer	0.000224	0.000494	CcSEcCtD
Phenylephrine—Dizziness—Irinotecan—breast cancer	0.000222	0.000489	CcSEcCtD
Phenylephrine—Shock—Capecitabine—breast cancer	0.000221	0.000487	CcSEcCtD
Phenylephrine—Nervous system disorder—Capecitabine—breast cancer	0.000221	0.000486	CcSEcCtD
Phenylephrine—Tachycardia—Capecitabine—breast cancer	0.000219	0.000483	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—breast cancer	0.000219	0.000481	CcSEcCtD
Phenylephrine—Skin disorder—Capecitabine—breast cancer	0.000218	0.000481	CcSEcCtD
Phenylephrine—Urticaria—Paclitaxel—breast cancer	0.000218	0.000479	CcSEcCtD
Phenylephrine—Hyperhidrosis—Capecitabine—breast cancer	0.000217	0.000479	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—breast cancer	0.000214	0.000471	CcSEcCtD
Phenylephrine—Vomiting—Mitoxantrone—breast cancer	0.000214	0.00047	CcSEcCtD
Phenylephrine—Vomiting—Irinotecan—breast cancer	0.000214	0.00047	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—breast cancer	0.000213	0.000469	CcSEcCtD
Phenylephrine—Dizziness—Fluorouracil—breast cancer	0.000213	0.000469	CcSEcCtD
Phenylephrine—Visual impairment—Epirubicin—breast cancer	0.000212	0.000468	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—breast cancer	0.000212	0.000468	CcSEcCtD
Phenylephrine—Rash—Mitoxantrone—breast cancer	0.000212	0.000466	CcSEcCtD
Phenylephrine—Rash—Irinotecan—breast cancer	0.000212	0.000466	CcSEcCtD
Phenylephrine—Dermatitis—Mitoxantrone—breast cancer	0.000212	0.000466	CcSEcCtD
Phenylephrine—Dermatitis—Irinotecan—breast cancer	0.000212	0.000466	CcSEcCtD
Phenylephrine—Headache—Irinotecan—breast cancer	0.00021	0.000463	CcSEcCtD
Phenylephrine—Headache—Mitoxantrone—breast cancer	0.00021	0.000463	CcSEcCtD
Phenylephrine—Paraesthesia—Docetaxel—breast cancer	0.000209	0.000459	CcSEcCtD
Phenylephrine—Vomiting—Gemcitabine—breast cancer	0.000208	0.000458	CcSEcCtD
Phenylephrine—Bradycardia—Doxorubicin—breast cancer	0.000208	0.000457	CcSEcCtD
Phenylephrine—Dyspnoea—Docetaxel—breast cancer	0.000207	0.000456	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—breast cancer	0.000206	0.000455	CcSEcCtD
Phenylephrine—Rash—Gemcitabine—breast cancer	0.000206	0.000454	CcSEcCtD
Phenylephrine—Dermatitis—Gemcitabine—breast cancer	0.000206	0.000454	CcSEcCtD
Phenylephrine—Headache—Gemcitabine—breast cancer	0.000205	0.000451	CcSEcCtD
Phenylephrine—Cardiac disorder—Epirubicin—breast cancer	0.000205	0.000451	CcSEcCtD
Phenylephrine—Vomiting—Fluorouracil—breast cancer	0.000205	0.00045	CcSEcCtD
Phenylephrine—Rash—Fluorouracil—breast cancer	0.000203	0.000447	CcSEcCtD
Phenylephrine—Dermatitis—Fluorouracil—breast cancer	0.000203	0.000446	CcSEcCtD
Phenylephrine—Paraesthesia—Capecitabine—breast cancer	0.000202	0.000445	CcSEcCtD
Phenylephrine—Hypersensitivity—Paclitaxel—breast cancer	0.000202	0.000445	CcSEcCtD
Phenylephrine—Headache—Fluorouracil—breast cancer	0.000202	0.000444	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—breast cancer	0.000201	0.000442	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000201	0.000441	CcSEcCtD
Phenylephrine—Dyspnoea—Capecitabine—breast cancer	0.0002	0.000441	CcSEcCtD
Phenylephrine—Angiopathy—Epirubicin—breast cancer	0.0002	0.00044	CcSEcCtD
Phenylephrine—Nausea—Irinotecan—breast cancer	0.0002	0.000439	CcSEcCtD
Phenylephrine—Nausea—Mitoxantrone—breast cancer	0.0002	0.000439	CcSEcCtD
Phenylephrine—Immune system disorder—Epirubicin—breast cancer	0.000199	0.000439	CcSEcCtD
Phenylephrine—Mediastinal disorder—Epirubicin—breast cancer	0.000199	0.000438	CcSEcCtD
Phenylephrine—Pain—Docetaxel—breast cancer	0.000199	0.000437	CcSEcCtD
Phenylephrine—Arrhythmia—Epirubicin—breast cancer	0.000197	0.000434	CcSEcCtD
Phenylephrine—Visual impairment—Doxorubicin—breast cancer	0.000197	0.000433	CcSEcCtD
Phenylephrine—Nausea—Gemcitabine—breast cancer	0.000194	0.000428	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Capecitabine—breast cancer	0.000194	0.000427	CcSEcCtD
Phenylephrine—Pruritus—Paclitaxel—breast cancer	0.000194	0.000427	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—breast cancer	0.000193	0.000426	CcSEcCtD
Phenylephrine—Mental disorder—Epirubicin—breast cancer	0.000193	0.000425	CcSEcCtD
Phenylephrine—Pain—Capecitabine—breast cancer	0.000192	0.000423	CcSEcCtD
Phenylephrine—Nausea—Fluorouracil—breast cancer	0.000191	0.000421	CcSEcCtD
Phenylephrine—Cardiac disorder—Doxorubicin—breast cancer	0.000189	0.000417	CcSEcCtD
Phenylephrine—Tension—Epirubicin—breast cancer	0.000188	0.000415	CcSEcCtD
Phenylephrine—Dysgeusia—Epirubicin—breast cancer	0.000188	0.000414	CcSEcCtD
Phenylephrine—Nervousness—Epirubicin—breast cancer	0.000186	0.00041	CcSEcCtD
Phenylephrine—Angiopathy—Doxorubicin—breast cancer	0.000185	0.000408	CcSEcCtD
Phenylephrine—Immune system disorder—Doxorubicin—breast cancer	0.000184	0.000406	CcSEcCtD
Phenylephrine—Mediastinal disorder—Doxorubicin—breast cancer	0.000184	0.000405	CcSEcCtD
Phenylephrine—Arrhythmia—Doxorubicin—breast cancer	0.000182	0.000401	CcSEcCtD
Phenylephrine—Dizziness—Paclitaxel—breast cancer	0.000181	0.000399	CcSEcCtD
Phenylephrine—Vision blurred—Epirubicin—breast cancer	0.000181	0.000398	CcSEcCtD
Phenylephrine—Mental disorder—Doxorubicin—breast cancer	0.000179	0.000394	CcSEcCtD
Phenylephrine—Urticaria—Capecitabine—breast cancer	0.000179	0.000393	CcSEcCtD
Phenylephrine—Agitation—Epirubicin—breast cancer	0.000176	0.000388	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—breast cancer	0.000175	0.000384	CcSEcCtD
Phenylephrine—Tension—Doxorubicin—breast cancer	0.000174	0.000384	CcSEcCtD
Phenylephrine—Vomiting—Paclitaxel—breast cancer	0.000174	0.000384	CcSEcCtD
Phenylephrine—Dysgeusia—Doxorubicin—breast cancer	0.000174	0.000383	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000173	0.000382	CcSEcCtD
Phenylephrine—Rash—Paclitaxel—breast cancer	0.000173	0.00038	CcSEcCtD
Phenylephrine—Dermatitis—Paclitaxel—breast cancer	0.000173	0.00038	CcSEcCtD
Phenylephrine—Nervousness—Doxorubicin—breast cancer	0.000172	0.00038	CcSEcCtD
Phenylephrine—Syncope—Epirubicin—breast cancer	0.000172	0.000379	CcSEcCtD
Phenylephrine—Headache—Paclitaxel—breast cancer	0.000172	0.000378	CcSEcCtD
Phenylephrine—Hypersensitivity—Docetaxel—breast cancer	0.000171	0.000377	CcSEcCtD
Phenylephrine—Palpitations—Epirubicin—breast cancer	0.00017	0.000373	CcSEcCtD
Phenylephrine—Loss of consciousness—Epirubicin—breast cancer	0.000169	0.000371	CcSEcCtD
Phenylephrine—Vision blurred—Doxorubicin—breast cancer	0.000167	0.000369	CcSEcCtD
Phenylephrine—Hypertension—Epirubicin—breast cancer	0.000166	0.000365	CcSEcCtD
Phenylephrine—Hypersensitivity—Capecitabine—breast cancer	0.000166	0.000365	CcSEcCtD
Phenylephrine—Pruritus—Docetaxel—breast cancer	0.000164	0.000362	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—breast cancer	0.000164	0.000361	CcSEcCtD
Phenylephrine—Chest pain—Epirubicin—breast cancer	0.000163	0.00036	CcSEcCtD
Phenylephrine—Agitation—Doxorubicin—breast cancer	0.000163	0.000359	CcSEcCtD
Phenylephrine—Nausea—Paclitaxel—breast cancer	0.000163	0.000358	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—breast cancer	0.000163	0.000358	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000162	0.000357	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—breast cancer	0.000162	0.000356	CcSEcCtD
Phenylephrine—Syncope—Doxorubicin—breast cancer	0.000159	0.000351	CcSEcCtD
Phenylephrine—Pruritus—Capecitabine—breast cancer	0.000159	0.00035	CcSEcCtD
Phenylephrine—Palpitations—Doxorubicin—breast cancer	0.000157	0.000346	CcSEcCtD
Phenylephrine—Loss of consciousness—Doxorubicin—breast cancer	0.000156	0.000344	CcSEcCtD
Phenylephrine—Shock—Epirubicin—breast cancer	0.000154	0.000339	CcSEcCtD
Phenylephrine—Nervous system disorder—Epirubicin—breast cancer	0.000154	0.000338	CcSEcCtD
Phenylephrine—Dizziness—Docetaxel—breast cancer	0.000154	0.000338	CcSEcCtD
Phenylephrine—Hypertension—Doxorubicin—breast cancer	0.000153	0.000338	CcSEcCtD
Phenylephrine—Tachycardia—Epirubicin—breast cancer	0.000153	0.000337	CcSEcCtD
Phenylephrine—Skin disorder—Epirubicin—breast cancer	0.000152	0.000335	CcSEcCtD
Phenylephrine—Hyperhidrosis—Epirubicin—breast cancer	0.000151	0.000333	CcSEcCtD
Phenylephrine—Chest pain—Doxorubicin—breast cancer	0.000151	0.000333	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—breast cancer	0.00015	0.000331	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.00015	0.000331	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—breast cancer	0.000149	0.000329	CcSEcCtD
Phenylephrine—Dizziness—Capecitabine—breast cancer	0.000149	0.000327	CcSEcCtD
Phenylephrine—Vomiting—Docetaxel—breast cancer	0.000148	0.000325	CcSEcCtD
Phenylephrine—Rash—Docetaxel—breast cancer	0.000146	0.000322	CcSEcCtD
Phenylephrine—Dermatitis—Docetaxel—breast cancer	0.000146	0.000322	CcSEcCtD
Phenylephrine—Headache—Docetaxel—breast cancer	0.000145	0.00032	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—breast cancer	0.000145	0.000318	CcSEcCtD
Phenylephrine—Pain—Methotrexate—breast cancer	0.000143	0.000315	CcSEcCtD
Phenylephrine—Vomiting—Capecitabine—breast cancer	0.000143	0.000315	CcSEcCtD
Phenylephrine—Shock—Doxorubicin—breast cancer	0.000143	0.000314	CcSEcCtD
Phenylephrine—Nervous system disorder—Doxorubicin—breast cancer	0.000142	0.000313	CcSEcCtD
Phenylephrine—Rash—Capecitabine—breast cancer	0.000142	0.000312	CcSEcCtD
Phenylephrine—Dermatitis—Capecitabine—breast cancer	0.000142	0.000312	CcSEcCtD
Phenylephrine—Tachycardia—Doxorubicin—breast cancer	0.000141	0.000311	CcSEcCtD
Phenylephrine—Headache—Capecitabine—breast cancer	0.000141	0.00031	CcSEcCtD
Phenylephrine—Skin disorder—Doxorubicin—breast cancer	0.000141	0.00031	CcSEcCtD
Phenylephrine—Paraesthesia—Epirubicin—breast cancer	0.000141	0.00031	CcSEcCtD
Phenylephrine—Hyperhidrosis—Doxorubicin—breast cancer	0.00014	0.000309	CcSEcCtD
Phenylephrine—Dyspnoea—Epirubicin—breast cancer	0.00014	0.000308	CcSEcCtD
Phenylephrine—Nausea—Docetaxel—breast cancer	0.000138	0.000304	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Epirubicin—breast cancer	0.000135	0.000298	CcSEcCtD
Phenylephrine—Pain—Epirubicin—breast cancer	0.000134	0.000295	CcSEcCtD
Phenylephrine—Nausea—Capecitabine—breast cancer	0.000134	0.000294	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—breast cancer	0.000133	0.000293	CcSEcCtD
Phenylephrine—Paraesthesia—Doxorubicin—breast cancer	0.00013	0.000287	CcSEcCtD
Phenylephrine—Dyspnoea—Doxorubicin—breast cancer	0.000129	0.000285	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000125	0.000276	CcSEcCtD
Phenylephrine—Urticaria—Epirubicin—breast cancer	0.000124	0.000274	CcSEcCtD
Phenylephrine—Pain—Doxorubicin—breast cancer	0.000124	0.000273	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—breast cancer	0.000123	0.000272	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—breast cancer	0.000118	0.000261	CcSEcCtD
Phenylephrine—Hypersensitivity—Epirubicin—breast cancer	0.000115	0.000254	CcSEcCtD
Phenylephrine—Urticaria—Doxorubicin—breast cancer	0.000115	0.000254	CcSEcCtD
Phenylephrine—Pruritus—Epirubicin—breast cancer	0.000111	0.000244	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—breast cancer	0.000111	0.000244	CcSEcCtD
Phenylephrine—Hypersensitivity—Doxorubicin—breast cancer	0.000107	0.000235	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—breast cancer	0.000106	0.000234	CcSEcCtD
Phenylephrine—Rash—Methotrexate—breast cancer	0.000106	0.000232	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—breast cancer	0.000105	0.000232	CcSEcCtD
Phenylephrine—Headache—Methotrexate—breast cancer	0.000105	0.000231	CcSEcCtD
Phenylephrine—Dizziness—Epirubicin—breast cancer	0.000104	0.000228	CcSEcCtD
Phenylephrine—Pruritus—Doxorubicin—breast cancer	0.000103	0.000226	CcSEcCtD
Phenylephrine—Vomiting—Epirubicin—breast cancer	9.96e-05	0.000219	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—breast cancer	9.94e-05	0.000219	CcSEcCtD
Phenylephrine—Rash—Epirubicin—breast cancer	9.88e-05	0.000217	CcSEcCtD
Phenylephrine—Dermatitis—Epirubicin—breast cancer	9.87e-05	0.000217	CcSEcCtD
Phenylephrine—Headache—Epirubicin—breast cancer	9.81e-05	0.000216	CcSEcCtD
Phenylephrine—Dizziness—Doxorubicin—breast cancer	9.59e-05	0.000211	CcSEcCtD
Phenylephrine—Nausea—Epirubicin—breast cancer	9.31e-05	0.000205	CcSEcCtD
Phenylephrine—Vomiting—Doxorubicin—breast cancer	9.22e-05	0.000203	CcSEcCtD
Phenylephrine—Rash—Doxorubicin—breast cancer	9.14e-05	0.000201	CcSEcCtD
Phenylephrine—Dermatitis—Doxorubicin—breast cancer	9.13e-05	0.000201	CcSEcCtD
Phenylephrine—Headache—Doxorubicin—breast cancer	9.08e-05	0.0002	CcSEcCtD
Phenylephrine—Nausea—Doxorubicin—breast cancer	8.61e-05	0.00019	CcSEcCtD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB3—breast cancer	1.87e-05	9.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGFR2—breast cancer	1.86e-05	9.39e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC2A2—breast cancer	1.86e-05	9.38e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SMAD4—breast cancer	1.86e-05	9.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH1—breast cancer	1.86e-05	9.35e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NOS3—breast cancer	1.85e-05	9.31e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1R—breast cancer	1.85e-05	9.3e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.84e-05	9.29e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL8—breast cancer	1.84e-05	9.26e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTR—breast cancer	1.82e-05	9.19e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCG2—breast cancer	1.82e-05	9.19e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CPT1A—breast cancer	1.82e-05	9.19e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APC—breast cancer	1.82e-05	9.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CG—breast cancer	1.82e-05	9.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KIT—breast cancer	1.82e-05	9.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HES1—breast cancer	1.81e-05	9.13e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NCOR1—breast cancer	1.8e-05	9.08e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PLA2G4A—breast cancer	1.8e-05	9.08e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—breast cancer	1.79e-05	9.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGF—breast cancer	1.79e-05	9.04e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HPGDS—breast cancer	1.79e-05	9.02e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TERT—breast cancer	1.79e-05	9.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGF1—breast cancer	1.78e-05	8.98e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CSF2—breast cancer	1.78e-05	8.98e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HBA1—breast cancer	1.78e-05	8.96e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RAF1—breast cancer	1.78e-05	8.96e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NRG1—breast cancer	1.77e-05	8.91e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—H2AFX—breast cancer	1.76e-05	8.85e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—breast cancer	1.76e-05	8.85e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—E2F1—breast cancer	1.74e-05	8.79e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK3—breast cancer	1.74e-05	8.76e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FGFR1—breast cancer	1.74e-05	8.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CB—breast cancer	1.74e-05	8.75e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ACHE—breast cancer	1.74e-05	8.74e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTT1—breast cancer	1.74e-05	8.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HIF1A—breast cancer	1.71e-05	8.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—BRAF—breast cancer	1.71e-05	8.6e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CB—breast cancer	1.71e-05	8.59e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—breast cancer	1.69e-05	8.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SPP1—breast cancer	1.68e-05	8.44e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LEP—breast cancer	1.67e-05	8.41e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL8—breast cancer	1.67e-05	8.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IGF1—breast cancer	1.66e-05	8.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT2—breast cancer	1.66e-05	8.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB3—breast cancer	1.66e-05	8.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGFR2—breast cancer	1.65e-05	8.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CAV1—breast cancer	1.65e-05	8.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EGFR—breast cancer	1.65e-05	8.33e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP17A1—breast cancer	1.64e-05	8.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KDR—breast cancer	1.64e-05	8.24e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ENO1—breast cancer	1.63e-05	8.19e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS1—breast cancer	1.63e-05	8.19e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.62e-05	8.16e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.6e-05	8.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CD—breast cancer	1.6e-05	8.04e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP2D6—breast cancer	1.59e-05	8.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—breast cancer	1.59e-05	8.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ESR1—breast cancer	1.59e-05	8.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TERT—breast cancer	1.59e-05	8e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—breast cancer	1.58e-05	7.96e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SERPINE1—breast cancer	1.58e-05	7.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—FN1—breast cancer	1.57e-05	7.93e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOA2—breast cancer	1.57e-05	7.89e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KRAS—breast cancer	1.56e-05	7.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NFKBIA—breast cancer	1.56e-05	7.84e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FGFR1—breast cancer	1.54e-05	7.77e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH1—breast cancer	1.54e-05	7.76e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HIF1A—breast cancer	1.52e-05	7.65e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—FASN—breast cancer	1.52e-05	7.65e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—BCHE—breast cancer	1.51e-05	7.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOS3—breast cancer	1.51e-05	7.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KIT—breast cancer	1.51e-05	7.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CG—breast cancer	1.51e-05	7.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APC—breast cancer	1.51e-05	7.59e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC5A5—breast cancer	1.49e-05	7.52e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGF—breast cancer	1.49e-05	7.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LEP—breast cancer	1.48e-05	7.47e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—breast cancer	1.47e-05	7.43e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CAV1—breast cancer	1.47e-05	7.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KDR—breast cancer	1.45e-05	7.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK3—breast cancer	1.44e-05	7.27e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NQO1—breast cancer	1.44e-05	7.27e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SLC2A1—breast cancer	1.44e-05	7.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—breast cancer	1.44e-05	7.23e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MDM2—breast cancer	1.43e-05	7.2e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RAF1—breast cancer	1.42e-05	7.18e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RELA—breast cancer	1.42e-05	7.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—BRAF—breast cancer	1.42e-05	7.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ESR1—breast cancer	1.42e-05	7.13e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.41e-05	7.12e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—ERBB2—breast cancer	1.41e-05	7.1e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP3A4—breast cancer	1.41e-05	7.09e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.4e-05	7.05e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—FN1—breast cancer	1.4e-05	7.05e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MTOR—breast cancer	1.39e-05	7.01e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CB—breast cancer	1.39e-05	7.01e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1B1—breast cancer	1.38e-05	6.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	1.38e-05	6.96e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IGF1—breast cancer	1.38e-05	6.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT2—breast cancer	1.38e-05	6.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EGFR—breast cancer	1.37e-05	6.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	1.37e-05	6.9e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.36e-05	6.83e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KIT—breast cancer	1.34e-05	6.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APC—breast cancer	1.34e-05	6.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	1.34e-05	6.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL8—breast cancer	1.34e-05	6.73e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRAS—breast cancer	1.33e-05	6.69e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CD—breast cancer	1.32e-05	6.67e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGF—breast cancer	1.32e-05	6.67e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOA1—breast cancer	1.32e-05	6.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—breast cancer	1.31e-05	6.61e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SERPINE1—breast cancer	1.31e-05	6.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1B—breast cancer	1.31e-05	6.58e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—STK11—breast cancer	1.3e-05	6.55e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP19A1—breast cancer	1.3e-05	6.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KRAS—breast cancer	1.3e-05	6.53e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—breast cancer	1.29e-05	6.51e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	1.28e-05	6.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CASP3—breast cancer	1.28e-05	6.45e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—breast cancer	1.28e-05	6.44e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—breast cancer	1.27e-05	6.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—BRAF—breast cancer	1.26e-05	6.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOS3—breast cancer	1.25e-05	6.3e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—breast cancer	1.25e-05	6.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—JUN—breast cancer	1.24e-05	6.26e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CTNNB1—breast cancer	1.23e-05	6.21e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IGF1—breast cancer	1.23e-05	6.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT2—breast cancer	1.22e-05	6.17e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.22e-05	6.15e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EGFR—breast cancer	1.22e-05	6.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—breast cancer	1.21e-05	6.09e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—COMT—breast cancer	1.21e-05	6.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CDKN1A—breast cancer	1.2e-05	6.07e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTP1—breast cancer	1.2e-05	6.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—breast cancer	1.2e-05	6.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	1.19e-05	6e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MDM2—breast cancer	1.19e-05	5.98e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—HMOX1—breast cancer	1.19e-05	5.98e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ITPR1—breast cancer	1.18e-05	5.96e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RAF1—breast cancer	1.18e-05	5.96e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RELA—breast cancer	1.18e-05	5.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	1.18e-05	5.93e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK8—breast cancer	1.18e-05	5.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—breast cancer	1.17e-05	5.91e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—ERBB2—breast cancer	1.17e-05	5.89e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	1.17e-05	5.87e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	1.16e-05	5.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MTOR—breast cancer	1.15e-05	5.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	1.15e-05	5.82e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KRAS—breast cancer	1.15e-05	5.8e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ABCB1—breast cancer	1.14e-05	5.74e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TYMS—breast cancer	1.12e-05	5.64e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SRC—breast cancer	1.11e-05	5.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOS3—breast cancer	1.11e-05	5.6e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL8—breast cancer	1.11e-05	5.59e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NCOR1—breast cancer	1.11e-05	5.57e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.11e-05	5.57e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—breast cancer	1.11e-05	5.57e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRAS—breast cancer	1.1e-05	5.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—breast cancer	1.09e-05	5.47e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.08e-05	5.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—breast cancer	1.07e-05	5.42e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.07e-05	5.4e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.06e-05	5.35e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—breast cancer	1.06e-05	5.34e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPX1—breast cancer	1.06e-05	5.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	1.06e-05	5.33e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.05e-05	5.32e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MDM2—breast cancer	1.05e-05	5.31e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RAF1—breast cancer	1.05e-05	5.29e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.05e-05	5.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RELA—breast cancer	1.05e-05	5.27e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—breast cancer	1.04e-05	5.24e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ERCC2—breast cancer	1.04e-05	5.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	1.04e-05	5.24e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.03e-05	5.21e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—JUN—breast cancer	1.03e-05	5.2e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK3—breast cancer	1.03e-05	5.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	1.03e-05	5.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MTOR—breast cancer	1.03e-05	5.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.02e-05	5.16e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—breast cancer	1e-05	5.06e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1e-05	5.04e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—breast cancer	9.99e-06	5.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—breast cancer	9.98e-06	5.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—breast cancer	9.96e-06	5.02e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	9.85e-06	4.97e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	9.79e-06	4.93e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—MTHFR—breast cancer	9.77e-06	4.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGFR—breast cancer	9.77e-06	4.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	9.76e-06	4.92e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	9.73e-06	4.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	9.62e-06	4.85e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	9.52e-06	4.8e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CASP3—breast cancer	9.43e-06	4.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—breast cancer	9.42e-06	4.75e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—breast cancer	9.37e-06	4.72e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SRC—breast cancer	9.25e-06	4.66e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KRAS—breast cancer	9.23e-06	4.65e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—breast cancer	9.18e-06	4.63e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—JUN—breast cancer	9.16e-06	4.62e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	9.09e-06	4.58e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CAV1—breast cancer	9.01e-06	4.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	9.01e-06	4.54e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—breast cancer	8.92e-06	4.5e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—breast cancer	8.91e-06	4.49e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	8.88e-06	4.47e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—breast cancer	8.86e-06	4.46e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	8.67e-06	4.37e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	8.64e-06	4.36e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.61e-06	4.34e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	8.52e-06	4.29e-05	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—breast cancer	8.49e-06	4.28e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	8.48e-06	4.27e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—breast cancer	8.29e-06	4.18e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	8.27e-06	4.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SRC—breast cancer	8.22e-06	4.14e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CG—breast cancer	8.21e-06	4.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—breast cancer	8.2e-06	4.13e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGFR—breast cancer	8.11e-06	4.09e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	8e-06	4.03e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—breast cancer	7.92e-06	3.99e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRAS—breast cancer	7.85e-06	3.95e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KRAS—breast cancer	7.66e-06	3.86e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	7.57e-06	3.81e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—breast cancer	7.51e-06	3.78e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—breast cancer	7.36e-06	3.71e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	7.35e-06	3.7e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CD—breast cancer	7.22e-06	3.64e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGFR—breast cancer	7.2e-06	3.63e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—breast cancer	7.12e-06	3.59e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	7.04e-06	3.55e-05	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—breast cancer	6.93e-06	3.49e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NOS3—breast cancer	6.81e-06	3.43e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—breast cancer	6.81e-06	3.43e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KRAS—breast cancer	6.8e-06	3.43e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRAS—breast cancer	6.51e-06	3.28e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CB—breast cancer	6.29e-06	3.17e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	6.25e-06	3.15e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—breast cancer	6.23e-06	3.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—breast cancer	6.23e-06	3.14e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—breast cancer	6.05e-06	3.05e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRAS—breast cancer	5.78e-06	2.91e-05	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—breast cancer	5.75e-06	2.9e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—breast cancer	5.54e-06	2.79e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—breast cancer	5.44e-06	2.74e-05	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—breast cancer	5.11e-06	2.57e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—breast cancer	3.83e-06	1.93e-05	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—breast cancer	3.13e-06	1.58e-05	CbGpPWpGaD
